Market cap
$31 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-25 Mln
-
ROE
-1.9 %
-
ROCE
-- %
-
Industry P/E
22.21
-
EV/EBITDA
-0.7
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-2.3
-
Face value
--
-
Shares outstanding
4,973,690
8 Years Aggregate
CFO
$-162.76 Mln
EBITDA
$-194.62 Mln
Net Profit
$-198.24 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Calyxt (CLXT)
| 164.5 | 50.3 | 23.9 | 70.2 | -55.4 | -53.3 | -- |
|
BSE Sensex*
| -11.1 | -4.0 | -9.7 | -8.5 | 7.0 | 8.7 | 11.3 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|
|
Calyxt (CLXT)
| -93.1 | -49.5 | -39.8 | -32.3 | -52.8 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Calyxt (CLXT)
|
19.5 | 31.3 | 0.3 | -32.7 | -10,164.7 | -14 | -- | 0.8 |
| 35.3 | 444.3 | 529.8 | 52.2 | 12.6 | 35.5 | 8.9 | 3.1 | |
| 21.3 | 8,950.2 | 12,601.5 | 222.8 | 2.1 | 58.7 | 41.3 | 19.2 | |
| 56.4 | 3,330.6 | 1,519.8 | 103.9 | 11.5 | 10.6 | 31.9 | 3.1 | |
| 17.5 | 1,398.0 | 2,021.0 | 46.6 | 3.9 | 5.3 | 30.6 | 2.1 | |
| 28.4 | 654.1 | 1,337.8 | 48.2 | 4.8 | 21.7 | 13.6 | 2.6 | |
| 2.5 | 808.3 | 5,961.5 | 9.1 | 2.1 | 0.8 | 83.3 | 0.7 | |
| 26.7 | 1,492.4 | 4,101.7 | -45.8 | 2.5 | 6.5 | 127.5 | 2.5 | |
| 11.9 | 1,135.4 | 3,726.9 | 183.9 | 8.2 | 22.5 | 6.6 | 1.7 | |
| 351.2 | 1,256.4 | 85.0 | 41.0 | 49.2 | -- | 31.7 | 58.7 |
Shareholding Pattern
View DetailsAbout Calyxt (CLXT)
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a... higher fiber content. It has a commercialization agreement with S&W Seed Company to enhance the quality of alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Read more
-
Pres, CEO & Director
Mr. Michael Allen Carr
-
Pres, CEO & Director
Mr. Michael Allen Carr
-
Headquarters
Roseville, MN
-
Website
FAQs for Calyxt (CLXT)
What is the current share price of Calyxt Inc (CLXT) Today?
The share price of Calyxt Inc (CLXT) is $19.51 (NASDAQ) as of 02-Aug-2023 09:30 EDT. Calyxt Inc (CLXT) has given a return of -55.44% in the last 3 years.
What is the current PB & PE ratio of Calyxt Inc (CLXT)?
Since, TTM earnings of Calyxt Inc (CLXT) is negative, P/E ratio is not available.
The P/B ratio of Calyxt Inc (CLXT) is 0.85 times as on 02-Aug-2023, a 73 discount to its peers’ median range of 3.11 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
-0.73
|
0.99
|
|
2021
|
-2.80
|
5.77
|
|
2020
|
-3.30
|
4.15
|
|
2019
|
-5.63
|
3.70
|
|
2018
|
-12.14
|
3.62
|
What is the 52 Week High and Low of Calyxt Inc (CLXT)?
The 52-week high and low of Calyxt Inc (CLXT) are Rs -- and Rs -- as of 18-May-2026.
What is the market cap of Calyxt Inc (CLXT)?
Calyxt Inc (CLXT) has a market capitalisation of $ 31 Mln as on 02-Aug-2023. As per SEBI classification, it is a company.
Should I invest in Calyxt Inc (CLXT)?
Before investing in Calyxt Inc (CLXT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.